Form D · Other Health Care
LANX INC
Broomfield, CO · CIK 0001424092
Offering snapshot reported Apr 19, 2013 · SEC filing
- Reported sold
- $15.1M Offering amount: $15.1M
- Investors reported
- 41 Form D · investor count
- Minimum accepted
- $340 Reported outside-investor minimum
- First sale
- Sep 10, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$8,692,936 → $15,090,295
- Reported investors39 → 41
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 19, 2013 | Amendment | $15,090,295 | $6,397,359vs Oct 11, 2012 | 41 | SEC filing |
| Mar 7, 2013 | Amendment | $507,088 | $179,688vs Jan 14, 2013 | 14 | SEC filing |
| Jan 14, 2013 | Amendment | $327,400 | $29,050vs Mar 16, 2012 | 12 | SEC filing |
| Oct 11, 2012 | Amendment | $8,692,936 | $2,011,947vs Sep 24, 2012 | 39 | SEC filing |
| Oct 10, 2012 | Initial | $1,006,018 | No comparison | 1 | SEC filing |
| Oct 10, 2012 | Initial | $43,500 | No comparison | 2 | SEC filing |
| Sep 24, 2012 | Initial | $6,680,989 | No comparison | 37 | SEC filing |
| Mar 16, 2012 | Amendment | $298,350 | $32,450vs Sep 26, 2011 | 10 | SEC filing |
| Dec 13, 2011 | Initial | $150,000 | No comparison | 2 | SEC filing |
| Sep 26, 2011 | Amendment | $265,900 | $17,200vs Feb 28, 2011 | 10 | SEC filing |
| Feb 28, 2011 | Amendment | $248,700 | $55,800vs Nov 19, 2010 | 10 | SEC filing |
| Nov 19, 2010 | Amendment | $192,900 | $36,000vs May 28, 2010 | 9 | SEC filing |
| May 28, 2010 | Amendment | $156,900 | $113,400vs Jul 29, 2009 | 9 | SEC filing |
| Dec 31, 2009 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Jul 29, 2009 | Initial | $43,500 | No comparison | 4 | SEC filing |
| Dec 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184534
Source: Form D, filed Apr 19, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Anderson | Director |
| Dana Cohen | Executive |
| Stephen Deitsch | Executive |
| Michael C. Fulton, M.D. | Director, Executive |
| Dan Gladney | Director, Executive |
| Dana Klapper Cohen | Executive |
| Shawn Mc Cormick | Director |
| Arda Minocherhomjee | Director |
| Arda Minocherhomjee, M.D. | Director |
| Allen Moseley | Director |
| Cliff Owens | Executive |
| Greg W. Paschke | Executive |
| Jonathan Scott | Executive |
| Jeffrey Thramann, M.D. | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
310 Interlocken Parkway Suite 120
Broomfield, CO, 80021
Broomfield, CO, 80021